Your browser doesn't support javascript.
loading
[Anti TNF-alpha treatment of a refractory polymyositis]. / Traitement d'une polymyosite réfractaire par anti TNF-alpha.
Wendling, D; Prati, C; Ornetti, P; Toussirot, E; Streit, G.
Afiliación
  • Wendling D; Service de Rhumatologie, CHU Jean-Minjoz, boulevard Fleming, 25030 Besançon cedex, France. daniel.wendling@ufc-chu.univ-fcomte.fr
Rev Med Interne ; 28(3): 194-5, 2007 Mar.
Article en Fr | MEDLINE | ID: mdl-17240483
INTRODUCTION: Anti TNF-alpha agents may represent a possibility of treatment in cases of refractory polymyositis. CASE REPORT: We report a case of polymyositis refractory to corticosteroids and immunosuppressive agents in whom adjunction of infliximab led to a mild and transient improvement, and a secondary improvement after discontinuation of the treatment. DISCUSSION: In the reported cases of polymyositis treated with infliximab or etanercept a short-term response was seen in 9 out of 11 cases. Adverse events of the treatment are mentioned, and should be taken into account in the decision of treatment.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa / Polimiositis / Antiinflamatorios / Anticuerpos Monoclonales Límite: Adult / Female / Humans Idioma: Fr Revista: Rev Med Interne Año: 2007 Tipo del documento: Article País de afiliación: Francia
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa / Polimiositis / Antiinflamatorios / Anticuerpos Monoclonales Límite: Adult / Female / Humans Idioma: Fr Revista: Rev Med Interne Año: 2007 Tipo del documento: Article País de afiliación: Francia